Jane Street’s AngioDynamics ANGO Stock Holding History

Jane Street’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-18,000	Closed	-$205K	–	11459
2026 Q1	$205K	Buy	+18,000	New	+$195K	﹤0.01%	10098
2025 Q4	–	Sell	-17,100	Closed	-$191K	–	11028
2025 Q3	$191K	Buy	+17,100	New	+$165K	﹤0.01%	9717

Other funds holding ANGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.7M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

WCM

Weber Capital Management San Francisco, California $118M AUM

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street's ANGO Position: Q2 2026 in Review

Jane Street sold out of AngioDynamics (ANGO) in Q2 2026, closing a stake of 101,934 shares — an estimated $1.16M sold.

Jane Street first reported a position in ANGO in Q2 2021 and held it in 16 quarters. The position peaked at $3.86M in Q4 2025. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

Jane Street reported no remaining AngioDynamics position as of Q2 2026 after selling out during the quarter.
Jane Street sold 101,934 AngioDynamics shares in Q2 2026, an estimated $1.16M.
Jane Street first reported a position in AngioDynamics in Q2 2021 and held it in 16 quarters.
Jane Street's AngioDynamics position peaked at $3.86M in Q4 2025.
161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.